Loading…
avatar for Jonathan Goldsmith

Jonathan Goldsmith

FDA
Associate Director for Rare Diseases, Office of New Drugs, CDER
Dr. Goldsmith is Associate Director for Rare Diseases in the Office of New Drugs/CDER/FDA. Prior to federal service, he was a tenured professor in academia and focused on clinical drug development in regulated industry, at NHLBI/NIH and at orphan disease foundations. He earned his medical degree from NYU School of Medicine, received post-graduate training in Internal Medicine at Vanderbilt University Hospitals, and completed specialty training in hematology at the University of North Carolina.

My Speakers Sessions

Monday, June 19
 

11:00am